## 

## 

|||Page|
|---|---|---|
|Charity information|||
|Report ofthe Trustees||2 —4|
|Independent<br>Auditors'|report|5 —7|
|Statement offinancial|activities||
|Balance sheet|||
|Statement ofcash flows||10|
|Notes to the financial|statements|11—17|





## 

## 

|Trustees||Carl Graham FCA||
|---|---|---|---|
|||Dr Baboo Kabra||
|Registered|Office|Wellesley House||
|||Duke ofWellington|Avenue|
|||Royal Arsenal||
|||London SE186SS||
|Accountants||Simpson Wreford LLP||
|||Wellesley House||
|||Duke ofWellington|Avenue|
|||Royal Arsenal||
|||London SE186SS||
|Auditors||DCP Accountants|LLP|
|||457 Southchurch<br>Road||
|||Southend-on-Sea||
|||Essex SS12PH||
|Bankers||Barclays Bank PLC||
|||54 Lombard Street||
|||London EC3P 3AH||
|Investment|Advisers|JMFinn and Co||
|||4 Coleman Street||
|||London EC2R 5TA||





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

||Notes|2021|2020|
|---|---|---|---|
|INCOME AND ENDOWMENTS||||
|Income from investments||202,255|254,734|
|Total income||202,255|254,734|
|EXPENDITURE||||
|Expenditure<br>on raising funds:||||
|Investment<br>management|costs|(13,247)|(14,941)|
|Expenditure<br>on charitable|activities|(206,032)|(232,876)|
|Total expenditure||(219,279)|(247,817)|
|Net (expenditure)/income|before gains and losses|||
|on investments||(17,024)|6,917|
|Net gains/(losses)<br>on investments||752,106|(904,680)|
|Net movement<br>in funds||735,082|(897,763)|
|Total funds brought forward||4,021,570|4,919,333|
|Total funds carried forward||4,756,652|4,021,570|





## 

## 

|||AS AT31|MARCH|2021|||
|---|---|---|---|---|---|---|
|||Notes|2021|||2020|
|FIXED ASSETS|||||||
|Investments||||4,681,808||3,990,259|
|CURRENT|ASSETS||||||
|Debtors||9|2,846||5,213||
|Cash at bank|and in hand||78,718||32,818||
||||81,564||38.031||
|CREDITORS|||||||
|Amounts<br>due|within one year|10|(6,720)||(6,720)||
|NET CURRENT ASSETS||||74,844||31,311|
|NET ASSETS||||4,756,652||4,021,570|
|FUNDS|||||||
|Unrestricted|fund|13||4,756,652||4,021,570|





## 

## 

## 

|FOR THE Y|EA|R ENDED|31MARCH 202|1|
|---|---|---|---|---|
|||Notes|2021|2020|
|Net cash used in operating<br>activities||12|(216,911)|(247837)|
|Cashflows frominvesting<br>activities:|||||
|Interest and dividends|||202,255|254,734|
|Proceeds from sale ofinvestments|||504,742|828,168|
|Purchase ofinvestments|||(444,186)|(824,428)|
|Net cash provided<br>by investing<br>activities|||262,811|258874|
|Change in cash and cash equivalents|in|the year|45,900|10,637|
|Cash and cash equivalent<br>brought forward|||32,818|22,181|
|Cash and cash equivalents<br>carried forward|||78,718|32418|





## 

## 

## 

## 

## 



# 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

|3.|INCOME F|ROM IN||VES|TMENT|S||
|---|---|---|---|---|---|---|---|
|||||||2021|2020|
|||||||g||
||UK dividends|||||197,480|246,815|
||Dividends<br>from outside|||ofthe UK||4,750|7,887|
||Interest received|||||25|32|
|||||||202,255|254,734|
|4.|INVESTMENT MANAGEMENT|||||COSTS||
|||||||2021|2020|
|||||||g|g|
||Stockbroker|administrative|||charges|13,247|14,941|
|||||||13,247|14,941|
|5.|EXPENDITURE ON|||CHARITABLE ACTIVITIES||||
|||||||2021|2020|
|||||||g||
||Accountancy|and trust||management||12,480|12,480|
||Auditor remuneration||—note 6|||3,600|3,600|
||Legal and professional|||fees||3,000||
||Grants issued|—note 7||||186,952|216,796|
|||||||206,032|232,876|
|6.|AUDITOR REMUNERATION|||||||
|||||||2021|2020|
|||||||g|g|
||Auditor remuneration||—audit fee|||3,600|3,600|
|||||||3,600|3,600|





## 

## 

## 

|ANALYSIS OF GRANTS|||
|---|---|---|
||2021|2020|
|Grants to Institutions:|||
|StRaphael's<br>Hospice|35,000|45,000|
|Trinity Hospice —Psychiatrist|26,151|26,150|
|Trinity Hospice<br>—Registrar|10,049|10,049|
|Bowel Cancer|15,000|15,000|
|Marie Curie|22,500|30,000|
|SW Thames Kidney Fund|15,252|18,597|
|Prostate Cancer|20,000|20,000|
|Teenage Cancer Trust||6,000|
|Action Medical Research|10,000|10,000|
|Stroke Association|20,000|20,000|
|Maggie Keswick Jencks Cancer Caring Centre|10,000|10,000|
||183,952|210,796|
|Grants to Individuals:|3,000|6,000|
|Total grants issued|186,952|216,796|





## 

## 

## 

## 

|INVESTMENTS|||
|---|---|---|
||2021|2020|
||f.||
|Balance brought<br>forward|3,990,259|4,$98,679|
|Additions<br>at cost|444,186|824,428|
|Disposal proceeds|(504,742)|(828,168)|
|Realised (loss)/gain|45,599|16,588|
|Unrealised<br>(loss)/gain|706,506|(921,268)|
|Balance carried forward|4,681,$08|3,990,259|



||||Market Value (K)|Market Value (K)|
|---|---|---|---|---|
||||2021|2020|
||Australia:||||
||National|Australia Bank|64,483|37,007|
||Sweden:||||
||Svenska|Handelsbanken|51,208|43,997|
||Germany:||||
||Siemens||89,342|50,699|
|9.|DEBTORS||||
||||2021|2020|
||Accrued|income|2,846|5,213|





## 

## 

## 

|CREDITORS|||
|---|---|---|
||2021|2020|
|Accruals|6,720|6,720|



## 

## 

|FROM OPERATING AC|T|IVITIES|||
|---|---|---|---|---|
||||2021|2020|
|||||g|
|Net movement<br>in funds|||735,082|(897,763)|
|Deduct interest and dividend||income shown|(202,255)|(254,734)|
|in investing<br>activities|||||
|Deduct gains/add<br>back losses||on investments|(752,105)|904,680|
|Decrease/(increase)<br>in debtors|||2,367|(20)|
|Net cash used in operating|activities||(216,911)|(247,837)|
|FUND MOVEMENT|||||
||||Unrestricted||
|Balance at 1 April 2020|||4,021,570||
|Movement<br>for the year|||735,082||
|Balance at 31March 2021|||4,756,652||